AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Carlisle, RC Bettinger, T Ogris, M Hale, S Mautner, V Seymour, LW
Citation: Rc. Carlisle et al., Adenovirus hexon protein enhances nuclear delivery and increases transgeneexpression of polyethylenimine/plasmid DNA vectors, MOL THER, 4(5), 2001, pp. 473-483

Authors: Fisher, KD Stallwood, Y Green, NK Ulbrich, K Mautner, V Seymour, LW
Citation: Kd. Fisher et al., Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies, GENE THER, 8(5), 2001, pp. 341-348

Authors: Chung-Faye, GA Chen, MJ Green, NK Burton, A Anderson, D Mautner, V Searle, PF Kerr, DJ
Citation: Ga. Chung-faye et al., In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase, GENE THER, 8(20), 2001, pp. 1547-1554

Authors: Bruder, CEG Hirvela, C Tapia-Paez, I Fransson, I Segraves, R Hamilton, G Zhang, XX Evans, DG Wallace, AJ Baser, ME Zucman-Rossi, J Hergersberg, M Boltshauser, E Papi, L Rouleau, GA Poptodorov, G Jordanova, A Rask-Andersen, H Kluwe, L Mautner, V Sainio, M Hung, G Mathiesen, T Moller, C Pulst, SM Harder, H Heiberg, A Honda, M Miimura, M Sahlen, S Blennow, E Albertson, DG Pinkel, D Dumanski, JP
Citation: Ceg. Bruder et al., High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH, HUM MOL GEN, 10(3), 2001, pp. 271-282

Authors: Young, LS Mautner, V
Citation: Ls. Young et V. Mautner, The promise and potential hazards of adenovirus gene therapy, GUT, 48(5), 2001, pp. 733-736

Authors: Stallwood, Y Fisher, KD Gallimore, PH Mautner, V
Citation: Y. Stallwood et al., Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients, GENE THER, 7(8), 2000, pp. 637-643

Authors: Fisher, KD Ulbrich, K Subr, V Ward, CM Mautner, V Blakey, D Seymour, LW
Citation: Kd. Fisher et al., A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression, GENE THER, 7(15), 2000, pp. 1337-1343

Authors: Ganly, I Mautner, V Balmain, A
Citation: I. Ganly et al., Productive replication of human adenoviruses in mouse epidermal cells, J VIROLOGY, 74(6), 2000, pp. 2895-2899

Authors: Weedon, SJ Green, NK McNeish, IA Gilligan, MG Mautner, V Wrighton, CJ Mountain, A Young, LS Kerr, DJ Searle, PF
Citation: Sj. Weedon et al., Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirusvector-mediated expression of E-coli nitroreductase, INT J CANC, 86(6), 2000, pp. 848-854

Authors: Latham, JPF Searle, PF Mautner, V James, ND
Citation: Jpf. Latham et al., Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: Construction and testing of a tissue-specific adenovirus vector, CANCER RES, 60(2), 2000, pp. 334-341

Authors: Mautner, V Bailey, A Steinthorsdottir, V Ullah, R Rinaldi, A
Citation: V. Mautner et al., Properties of the adenovirus type 40 E1B promoter that contribute to its low transcriptional activity, VIROLOGY, 265(1), 1999, pp. 10-19
Risultati: 1-11 |